NPCE: Neuropace, Inc. Common Stock Company Profile & Statistics

About

NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.

Info & Links

CEO

Joel Becker

Headquarters

455 N. BERNARDO AVENUE
MOUNTAIN VIEW, CA 94043, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

145

Employees

184

Neuropace, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

329.51M

Enterprise Value

375.60M

Enterprise Value/EBITDA(ttm)

-17.69

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.56

Price to Book(mrq)

42.30

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

73.91%

Operating Margin(ttm)

-36.74%

Profit Margin(ttm)

-34.65%

Return on Equity(ttm)

-205.41%

Return on Invested Capital(ttm)

-38.90%

Return on Assets(ttm)

-28.29%

Income Statement

Revenue(ttm)

79.91M

Revenue Per Share(ttm)

2.45

Gross Profit(ttm)

59.08M

EBITDA(ttm)³

-21.24M

Net Income Available to Common(ttm)

-27.14M

Diluted EPS(ttm)

-1.00

Share Statistics

Beta (5Y Monthly)

2.05

52-Week Change

-22.76%

S&P 500 52-Week Change

6.83%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

32.56M

Dividend Yield

0.00%

Float⁴

23.22M

% Held by Insiders

22.20%

% Held by Institutions

78.83%

Balance Sheet

Total Cash(mrq)

52.76M

Total Cash Per Share(mrq)

1.62

Total Debt(mrq)

59.52M

Total Debt/Equity(mrq)

742.86%

Current Ratio(mrq)

5.37%

Quick Ratio(mrq)

4.77%

Book Value Per Share(mrq)

0.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-18.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NPCE

Neuropace, Inc. Common Stock

Neuropace, Inc. Common Stock Profile